Telix ARTMS Inc. – Trademark Portfolio
Entity Type: 99
Telix ARTMS Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include QIS, ARTMS, and QUANTM.
180 Bay Street,
Suite 1800 Toronto ON M5J 2T9
Showing of trademarks Trademarks
Trademark Classifications
Telix ARTMS Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Telix ARTMS Inc. have?
Telix ARTMS Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does Telix ARTMS Inc. file in?
Telix ARTMS Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Telix ARTMS Inc.'s most well-known trademarks?
Telix ARTMS Inc.'s registered trademark portfolio includes well-known marks such as QIS, ARTMS, and QUANTM. These are among 4 currently registered trademarks in the portfolio.
What is Telix ARTMS Inc.'s trademark registration success rate?
Telix ARTMS Inc. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.